Exos TFP Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,866
Closed -$961K 268
2023
Q1
$961K Buy
13,866
+7,217
+109% +$509K 0.24% 122
2022
Q4
$478K Buy
6,649
+3,296
+98% +$249K 0.13% 156
2022
Q3
$238K Buy
+3,353
New +$243K 0.11% 198

Other funds holding BMY

Exos TFP Holdings's BMY Position: Q2 2023 in Review

Exos TFP Holdings sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 13,866 shares — an estimated $961K sold.

Exos TFP Holdings first reported a position in BMY in Q3 2022 and held it in 3 quarters. The position peaked at $961K in Q1 2023. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Exos TFP Holdings reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 13,866 Bristol-Myers Squibb shares in Q2 2023, an estimated $961K.
  • Exos TFP Holdings first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 3 quarters.
  • Exos TFP Holdings's Bristol-Myers Squibb position peaked at $961K in Q1 2023.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.